Soluble IgM Links Apoptosis to Complement Activation in Early Alcoholic Liver Disease in Mice

Overview

Journal Mol Immunol

Specialties Allergy & Immunology
Molecular Biology

Date 2016 Feb 29

PMID 26922040

Citations 12

Authors

Rebecca L Smathers

Dian J Chiang

Megan R McMullen

Ariel E Feldstein

Sanjoy Roychowdhury

Laura E Nagy

Affiliations

Soon will be listed here.

Abstract

Background: Ethanol feeding in mice activates complement via C1q binding to apoptotic cells in the liver; complement contributes to ethanol-induced inflammation and injury. Despite the critical role of C1q in ethanol-induced injury, the mechanism by which ethanol activates C1q remains poorly understood. Secretory IgM (sIgM), traditionally considered to act as an anti-microbial, also has critical housekeeping functions, facilitating clearance of apoptotic cells, at least in part through activation of C1q. Therefore, we hypothesized that (1) ethanol-induced apoptosis in the liver recruits sIgM, facilitating the activation of C1q and complement and (2) C1INH (C1 esterase inhibitor), which inhibits C1 functional activity, prevents complement activation and decreases ethanol-induced liver injury.

Methods: Female C57BL/6 wild-type, C1qa(-/-), BID(-/-) and sIgM(-/-) mice were fed ethanol containing liquid diets or pair-fed control diets. C1INH or vehicle was given via tail vein injection to ethanol- or pair-fed wild-type mice at 24 and 48h prior to euthanasia.

Results: Ethanol exposure increased apoptosis in the liver, as well as the accumulation of IgM in the liver. In the early stages of ethanol feeding, C1q co-localized with IgM in the peri-sinusoidal space of the liver and accumulation of IgM and C3b was dependent on ethanol-induced BID-dependent apoptosis. sIgM(-/-) mice were protected from both ethanol-induced activation of complement and early ethanol-induced liver injury when compared to wild-type mice. Treatment with C1INH also decreased hepatic C3b deposition and ethanol-induced injury.

Conclusion: These data indicate that sIgM contributes to activation of complement and ethanol-induced increases in inflammatory cytokine expression and hepatocyte injury in the early stages of ethanol-induced liver injury.

Citing Articles

Noninvasive Biomarkers for Alcohol-Related Liver Disease-A Proteomic Related Preliminary Report.

Nelaturi P, Kademani S, Siva Subramanian V, Ravikumar S Indian J Clin Biochem. 2024; 39(3):392-400.

PMID: 39005863 PMC: 11239637. DOI: 10.1007/s12291-023-01120-9.

Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis.

Taiwo M, Huang E, Pathak V, Bellar A, Welch N, Dasarathy J JCI Insight. 2024; 9(9).

PMID: 38573776 PMC: 11141929. DOI: 10.1172/jci.insight.174127.

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease.

Wu X, Fan X, Miyata T, Kim A, Cajigas-Du Ross C, Ray S Annu Rev Pathol. 2022; 18:411-438.

PMID: 36270295 PMC: 10060166. DOI: 10.1146/annurev-pathmechdis-031521-030435.

Profiling the oxylipidome in aged mice after chronic ethanol feeding: Identifying lipid metabolites as drivers of hepatocyte stress.

Anton P, Rutt L, Capper C, Orlicky D, McCullough R Alcohol. 2022; 107:119-135.

PMID: 36150611 PMC: 10229104. DOI: 10.1016/j.alcohol.2022.08.012.

Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice.

Guo Z, Chen J, Zeng Y, Wang Z, Yao M, Tomlinson S Front Immunol. 2022; 12:785287.

PMID: 35069557 PMC: 8777082. DOI: 10.3389/fimmu.2021.785287.

References

Yin X, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B . Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature. 1999; 400(6747):886-91. DOI: 10.1038/23730. View

Lieber C . Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol. 2000; 32(1 Suppl):113-28. DOI: 10.1016/s0168-8278(00)80420-1. View

Mastellos D, Papadimitriou J, Franchini S, Tsonis P, Lambris J . A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J Immunol. 2001; 166(4):2479-86. DOI: 10.4049/jimmunol.166.4.2479. View

Kim S, Gershov D, Ma X, Brot N, Elkon K . I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med. 2002; 196(5):655-65. PMC: 2194002. DOI: 10.1084/jem.20020542. View

Jarvelainen H, Vakeva A, Lindros K, Meri S . Activation of complement components and reduced regulator expression in alcohol-induced liver injury in the rat. Clin Immunol. 2002; 105(1):57-63. DOI: 10.1006/clim.2002.5267. View

Liu D, Cai S, Gu X, Scafidi J, Wu X, Davis 3rd A . C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide. J Immunol. 2003; 171(5):2594-601. DOI: 10.4049/jimmunol.171.5.2594. View

Nagy L . Molecular aspects of alcohol metabolism: transcription factors involved in early ethanol-induced liver injury. Annu Rev Nutr. 2004; 24:55-78. DOI: 10.1146/annurev.nutr.24.012003.132258. View

Zwart B, Ciurana C, Rensink I, Manoe R, Hack C, Aarden L . Complement activation by apoptotic cells occurs predominantly via IgM and is limited to late apoptotic (secondary necrotic) cells. Autoimmunity. 2004; 37(2):95-102. DOI: 10.1080/0891693042000196183. View

Daveau M, Benard M, Scotte M, Schouft M, Hiron M, Francois A . Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat. J Immunol. 2004; 173(5):3418-24. DOI: 10.4049/jimmunol.173.5.3418. View

10.

Mandayam S, Jamal M, Morgan T . Epidemiology of alcoholic liver disease. Semin Liver Dis. 2004; 24(3):217-32. DOI: 10.1055/s-2004-832936. View

11.

Gasque P . Complement: a unique innate immune sensor for danger signals. Mol Immunol. 2004; 41(11):1089-98. DOI: 10.1016/j.molimm.2004.06.011. View

12.

Quartier P, Potter P, Ehrenstein M, Walport M, Botto M . Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur J Immunol. 2004; 35(1):252-60. DOI: 10.1002/eji.200425497. View

13.

Cicardi M, Zingale L, Zanichelli A, Pappalardo E, Cicardi B . C1 inhibitor: molecular and clinical aspects. Springer Semin Immunopathol. 2005; 27(3):286-98. DOI: 10.1007/s00281-005-0001-4. View

14.

Qin X, Gao B . The complement system in liver diseases. Cell Mol Immunol. 2006; 3(5):333-40. View

15.

Bykov I, Jauhiainen M, Olkkonen V, Saarikoski S, Ehnholm C, Junnikkala S . Hepatic gene expression and lipid parameters in complement C3(-/-) mice that do not develop ethanol-induced steatosis. J Hepatol. 2007; 46(5):907-14. DOI: 10.1016/j.jhep.2006.11.020. View

16.

Pritchard M, McMullen M, Stavitsky A, Cohen J, Lin F, Medof M . Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology. 2007; 132(3):1117-1126. PMC: 1838572. DOI: 10.1053/j.gastro.2007.01.053. View

17.

Fraser D, Tenner A . Directing an appropriate immune response: the role of defense collagens and other soluble pattern recognition molecules. Curr Drug Targets. 2008; 9(2):113-22. DOI: 10.2174/138945008783502476. View

18.

Roychowdhury S, McMullen M, Pritchard M, Hise A, van Rooijen N, Medof M . An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology. 2009; 49(4):1326-34. PMC: 2666108. DOI: 10.1002/hep.22776. View

19.

Sjoberg A, Trouw L, Blom A . Complement activation and inhibition: a delicate balance. Trends Immunol. 2009; 30(2):83-90. DOI: 10.1016/j.it.2008.11.003. View

20.

Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M . C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med. 2009; 15(2):69-78. DOI: 10.1016/j.molmed.2008.12.001. View